Dr. Wang's current research interests include developing new generation aptamers for cell, tissue and proteomics based aptamer selection and targeted immunotherapy. A nanobead library of chemically-modified DNA aptamers will be used to simultaneously discover high affinity aptamer sequences and associated target proteins as biomarkers for diagnostics, imaging and therapies. Ultimately, the selected aptamers are going to be used as an alternate of antibodies for targeted immunotherapies.
Publications/Creative Works
Click here to search for this faculty member's publications on PubMed.
Important Disclaimer: The responsibility for the accuracy of the information contained on these pages lies with the authors and user providing such information.